Valuation: Gland Pharma Limited

Market Cap 430B 4.51B 3.91B 3.67B 3.35B 6.33B 6.41B 42.89B 16.83B 215B 16.94B 16.57B 715B P/E 2027 *
34.5x
P/E 2028 * 28.1x
Enterprise Value 393B 4.13B 3.58B 3.35B 3.07B 5.79B 5.87B 39.22B 15.39B 196B 15.49B 15.15B 654B EV / Sales 2027 *
5.37x
EV / Sales 2028 * 4.61x
Free-Float
48.23%
Yield 2027 *
0.75%
Yield 2028 * 0.82%
1 day-1.16%
1 week+3.00%
Current month+3.00%
1 month+1.10%
3 months+37.82%
6 months+36.78%
Current year+49.71%
1 week 2,494.1
Extreme 2494.1
2,634.3
1 month 2,351.1
Extreme 2351.1
2,634.3
Current year 1,573.6
Extreme 1573.6
2,634.3
1 year 1,573.6
Extreme 1573.6
2,634.3
3 years 1,277.8
Extreme 1277.8
2,634.3
5 years 861
Extreme 861
4,350
10 years 861
Extreme 861
4,350
Manager TitleAgeSince
Director of Finance/CFO - 2019-09-29
Chief Operating Officer - 2026-04-05
Chief Tech/Sci/R&D Officer - 2026-02-17
Director TitleAgeSince
Chairman 57 2024-06-09
Director/Board Member 71 2018-02-06
Director/Board Member 69 2021-05-16
Date Insider Type Main position Quantity % Market Cap.
2/26/25 Buy 2,800 0.0017%
6/28/24 Sell 1,950 0.0012%
6/28/24 Sell 1,400 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-1.07%+3.00%+31.68%+92.02% 4.51B
+1.89%+3.20%+59.70%+165.18% 1,062B
-0.24%+0.45%+50.64%+52.02% 619B
-0.95%-5.26%+24.23%+65.08% 431B
+1.93%+5.12%+49.22%+40.34% 358B
+0.85%-0.11%+35.91%+40.75% 293B
+1.46%-4.47%+10.20%+10.85% 247B
-0.73%+4.44%+42.22%+66.41% 219B
+3.97%-0.60%-1.36%-44.17% 200B
-0.68%-0.32%+18.66%+66.32% 162B
Average +0.35%-1.35%+32.11%+55.48% 359.68B
Weighted average by Cap. +0.11%-0.82%+41.16%+78.32%

Financials

2027 *2028 *
Net sales 73.22B 769M 667M 625M 571M 1.08B 1.09B 7.31B 2.87B 36.59B 2.89B 2.82B 122B 83.28B 874M 759M 710M 650M 1.23B 1.24B 8.31B 3.26B 41.61B 3.28B 3.21B 138B
Net income 12.48B 131M 114M 106M 97.35M 184M 186M 1.25B 489M 6.23B 492M 481M 20.75B 15.31B 161M 139M 131M 119M 226M 228M 1.53B 600M 7.65B 603M 590M 25.46B
Net Debt -36.72B -385M -334M -313M -287M -541M -548M -3.66B -1.44B -18.34B -1.45B -1.42B -61.06B -46.04B -483M -419M -393M -359M -678M -687M -4.59B -1.8B -23B -1.81B -1.78B -76.57B
Logo Gland Pharma Limited
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.
Employees
4,332
Date Price Change Volume
26-08-07 2,580.40 -1.07% 103,756
26-08-06 ₹2,608.30 +2.48% 503,618
26-08-05 ₹2,545.10 -1.47% 299,935
26-08-04 ₹2,583.10 +0.15% 765,513
26-08-03 ₹2,579.20 +3.05% 502,554
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,608.30INR
Average target price
2,325.29INR
Spread / Average Target
-10.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GLAND Stock